Newsletter Subscribe
Enter your email address below and subscribe to our newsletter
Treatment
Share your love
Vyjuvek Restores Vision in Teen with Rare Genetic Condition
Krystal Biotech’s topical gene therapy Vyjuvek (beremagene-geperpavec) has successfully restored the vision of a 13-year-old boy suffering from the rare genetic condition dystrophic epidermolysis bullosa (DEB), which scarred his eyes. The groundbreaking case, detailed in a recent publication in The…
Novel Protocol to Rapidly Diagnose Eye Stroke
Ophthalmologists at New York Eye and Ear Infirmary of Mount Sinai (NYEE) have pioneered a novel protocol aimed at swiftly diagnosing eye stroke and expediting care to prevent irreversible vision loss. Published in Ophthalmology, their study outlines the use of…
2023 Recap: Top 10 Acquisitions in the Ophthalmic Industry
In 2023, the ophthalmic industry witnessed a transformative landscape shaped by strategic company acquisitions, setting the stage for significant advancements and collaborations. The top 10 acquisitions of the year highlighted a dynamic shift in the competitive dynamics of the sector.…
Meridian Medical Introduces Ophthalmic Laser Line in US
Meridian Medical, headquartered in Switzerland, announced the launch of its line of ophthalmic lasers in the United States, following a series of FDA approvals. The FDA approval, received on January 25, includes the MR Q family of lasers, which offer…
Low-Dose Atropine Eye Drops & Myopia Progression
According to the National Eye Institute (NEI), a trial conducted by the Pediatric Eye Disease Investigator Group (PEDIG) and funded by the NEI revealed that the use of low-dose atropine eye drops (concentration 0.01%) did not demonstrate superiority over a…
Glaukos Secures FDA Approval for iDose TR
Glaukos has received FDA approval for iDose TR (travoprost intracameral implant 75 mcg), a groundbreaking prostaglandin analog intracameral implant designed to reduce intraocular pressure (IOP) in individuals with ocular hypertension or open-angle glaucoma. The iDose TR procedure, sanctioned for a…
What Is Stargardt Disease? | OBN
What Is Stargardt Disease? Stargardt disease, also known as Stargardt macular degeneration or juvenile macular degeneration, is an inherited eye disease that affects the macula, which is the central part of the retina responsible for sharp, central vision. Stargardt disease…
Top 10 Trends to Watch in Ophthalmology
The field of ophthalmology is constantly evolving with new technologies and treatments emerging every year. In the next decade, we can expect even more advancements that will revolutionize the way we approach eye care. Here are the top 10 eye…
Japanese Astellas Pharma Acquires Iveric Bio for $5.9 Billion
Astellas Pharma, a Japanese drugmaker, announced the acquisition of Iveric Bio, a pharmaceutical company that is currently in the late stages of developing a geographic atrophy drug. The acquisition is valued at $5.9 billion, and under the terms of the…
Ophthalmology’s Leap with Emerging Technologies
In a recent survey conducted on LinkedIn by the Ophthalmology Breaking News (OBN), ophthalmology professionals were asked to identify the emerging technology they believed held the most promise for improving surgical outcomes in their field. The results shed light on…